BIOMAT Database Logo BIOMAT Database Logo

Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment. 1976

D H Wiles, and T Kolakowska, and A S McNeilly, and B M Mandelbrote, and M G Gelder

Seventeen acute psychotic patients were studied in the course of chlorpromazine (CPZ) treatment. Blood samples were taken weekly both before and two hours after the morning CPZ dose. Plasma levels of CPZ, CPZ sulphoxide (CPZ SO) monodesmethylated CPZ (NOR1CPZ) and 7-hydroxy CPZ (7OH CPZ) were estimated by gas chromatography. Plasma prolactin, luteinizing hormone, testosterone and oestrogens were measured by radioimmunoassay. Six of the seven patients who showed no clinical improvement had plasma CPZ levels equal to or higher than those of patients who improved. 'Non-responders' has a greater proportion of CPZ SO in pre-dosage samples. The occurrence of parkinsonian side effects was associated with a mean plasma CPZ of greater than 50 ng/ml and a mean plasma prolactin of greater than 30 ng/ml two hours after dosage. The elevation of prolactin preceded the onset of parkinsonian symptoms by 1-2 weeks. There was a significant positive correlation between mean plasma prolactin and mean plasma CPZ levels. The prolactin response may prove a useful index of the central antidopaminergic effect of neuroleptic drugs.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010259 Paranoid Disorders Chronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system (persecutory delusions or delusions of jealousy), accompanied by preservation of clear and orderly thinking. Emotional responses and behavior are consistent with the delusional state. Paranoia,Paranoid Psychoses,Psychoses, Paranoid,Disorder, Paranoid,Disorders, Paranoid,Paranoias,Paranoid Disorder
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D011644 Puerperal Disorders Disorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans. Disorder, Puerperal,Disorders, Puerperal,Puerperal Disorder
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females

Related Publications

D H Wiles, and T Kolakowska, and A S McNeilly, and B M Mandelbrote, and M G Gelder
Effect of metabolites of chlorpromazine on plasma prolactin levels in male rats.
February 1977, European journal of pharmacology,
D H Wiles, and T Kolakowska, and A S McNeilly, and B M Mandelbrote, and M G Gelder
Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patients.
January 1968, Life sciences,
D H Wiles, and T Kolakowska, and A S McNeilly, and B M Mandelbrote, and M G Gelder
Effects of chlorpromazine on plasma prolactin and chlorpromazine levels [proceedings].
January 1977, Psychopharmacology bulletin,
D H Wiles, and T Kolakowska, and A S McNeilly, and B M Mandelbrote, and M G Gelder
Importance of akinesia: plasma chlorpromazine and prolactin levels.
November 1980, The American journal of psychiatry,
D H Wiles, and T Kolakowska, and A S McNeilly, and B M Mandelbrote, and M G Gelder
[Clinical significance of plasma levels of clomipramine and its desmethylated and hydroxylated metabolites].
August 1993, Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology,
D H Wiles, and T Kolakowska, and A S McNeilly, and B M Mandelbrote, and M G Gelder
Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
January 1981, Psychopharmacology,
D H Wiles, and T Kolakowska, and A S McNeilly, and B M Mandelbrote, and M G Gelder
Interactions between chlorpromazine and some of its metabolites.
January 1980, Communications in psychopharmacology,
D H Wiles, and T Kolakowska, and A S McNeilly, and B M Mandelbrote, and M G Gelder
Plasma levels and half lives of thioridazine and some of its metabolites. I. High doses in young acute schizophrenics.
January 1977, European journal of clinical pharmacology,
D H Wiles, and T Kolakowska, and A S McNeilly, and B M Mandelbrote, and M G Gelder
Radioassay of chlorpromazine and its metabolites in plasma.
January 1971, Psychopharmacologia,
D H Wiles, and T Kolakowska, and A S McNeilly, and B M Mandelbrote, and M G Gelder
Plasma levels of mesoridazine and its metabolites and clinical response in acute schizophrenia after a single intramuscular drug dose.
October 1975, Psychopharmacology bulletin,
Copied contents to your clipboard!